Long-Term Safety Of Fixed-Dose Combination Aclidinium Bromide/formoterol Fumarate In Patients With Moderate To Severe COPD: The Augment COPD Extension Trial

被引：0
|
作者：
Rennard, S. I. [1 ]
D'Urzo, A. D. [2 ]
Donohue, J. F. [3 ]
He, T. [4 ]
Shrestha, P. [4 ]
Leselbaum, A. [5 ]
Caracta, C. [4 ]
机构：
[1] Univ Nebraska Med Ctr, Omaha, NE USA
[2] Univ Toronto, Toronto, ON, Canada
[3] Univ N Carolina, Chapel Hill, NC USA
[4] Forest Res Inst, Jersey City, NJ USA
[5] Almirall SA, Barcelona, Spain
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2014年 / 189卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A6008
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Long-term safety and efficacy of formoterol fumarate inhalation solution in patients with moderate-to-severe COPD
    Hanania, Nicola A.
    Sethi, Sanjay
    Koltun, Arkady
    Ward, Jonathan K.
    Spanton, Jacqui
    Ng, Dik
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2019, 14 : 117 - 127
  • [32] Efficacy and tolerability of aclidinium bromide/fomoterol fumarate fixed-dose combination in patients with COPD: A 1-year study
    Make, Barry
    Donohue, James
    Soong, Weily
    Zhong, Xiaoyun
    Leselbaum, Anne
    Caracta, Cynthia
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [33] Long-term Cardiovascular Safety of Aclidinium Bromide in Patients With COPD
    Donohue, James
    Tashkin, Donald
    Ferguson, Gary
    Kowey, Peter
    Rekeda, Ludmyla
    Shrestha, Pomy
    Gil, Esther Garcia
    Caracta, Cynthia
    CHEST, 2013, 144 (04)
  • [34] The Effect Of Aclidinium/formoterol Fixed-Dose Combination On COPD Symptoms And Health Status In Patients With COPD: Results From The Acliform/COPD Study
    Jones, P. W.
    Singh, D.
    Bateman, E. D.
    Korn, S.
    Serra, C.
    Molins, E.
    Caracta, C.
    Leselbaum, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [35] Aclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomised studies (ACLIFORM and AUGMENT)
    Bateman, Eric D.
    Chapman, Kenneth R.
    Singh, Dave
    D'Urzo, Anthony D.
    Molins, Eduard
    Leselbaum, Anne
    Garcia Gil, Esther
    RESPIRATORY RESEARCH, 2015, 16
  • [36] Efficacy and safety of aclidinium/formoterol fixed-dose combination in patients with moderate to severe airflow obstruction, stratified by severity ;
    D'Urzo, Anthony D.
    Singh, Dave
    Kerwin, Edward
    Lakkis, Hassan
    Chuecos, Ferran
    De Miguel, Gonzalo
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [37] Effect of aclidinium/formoterol fixed-dose combinations on respiratory symptoms in COPD patients
    Jones, Paul
    D'Urzo, Anthony
    Rennard, Stephen
    Molins, Eduard
    Mergel, Victor
    Caracta, Cynthia
    Leselbaum, Anne
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [38] Aclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomised studies (ACLIFORM and AUGMENT)
    Eric D. Bateman
    Kenneth R. Chapman
    Dave Singh
    Anthony D. D’Urzo
    Eduard Molins
    Anne Leselbaum
    Esther Garcia Gil
    Respiratory Research, 16
  • [39] Aclidinium bromide/formoterol fumarate fixed-dose combination for the treatment of chronic obstructive pulmonary disease
    Cazzola, Mario
    Rogliani, Paola
    Matera, Maria Gabriella
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (06) : 775 - 781
  • [40] Aclidinium/formoterol Fixed-Dose Combination Improves Bronchodilation And Is Well Tolerated In Patients With COPD: Results From The Acliform/COPD Study
    Singh, D.
    Jones, P. W.
    Bateman, E. D.
    Korn, S.
    Serra, C.
    Molins, E.
    Caracta, C.
    Leselbaum, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
12345